Rosemont And Hyloris Agree US Tie-Up On Valacyclovir
Firms Strike Deal On Oral Suspension Version Of Antiviral
Rosemont Pharmaceuticals will commercialize Hyloris’ proprietary valacyclovir oral suspension in the US under a new partnership that has been agreed between the two firms.
